Teva Pharma's most recent trend suggests a bearish bias. One trading opportunity on Teva Pharma is a Bear Call Spread using a strike $67.50 short call and a strike $72.50 long call offers a potential 5.49% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $67.50 by expiration. The full premium credit of $0.26 would be kept by the premium seller. The risk of $4.74 would be incurred if the stock rose above the $72.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Teva Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Teva Pharma is bearish.
The RSI indicator is at 51.71 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Teva Pharma
Meet Pharma’s Newest Movers and Shakers
Thu, 23 Apr 2015 04:36:43 GMT
Wed, 22 Apr 2015 22:06:38 GMT
AP – ___ EU alleges Google's abuses hurt consumers, innovation The European Union has charged Google with abusing its dominance in Internet searches and opened a probe into its Android mobile system. The legal …
Mylan Should Either Find A Friendly Suitor Or Negotiate A Better Deal With Teva
Wed, 22 Apr 2015 21:02:00 GMT
The Mylan–Teva Deal: Arbitrage Spread Analysis
Wed, 22 Apr 2015 18:33:07 GMT
Teva Pharmaceuticals Makes a Hostile Bid for Mylan
Wed, 22 Apr 2015 18:33:02 GMT
Also on Market Tamer…
Follow Us on Facebook